Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.430
-0.030 (-1.22%)
At close: Oct 3, 2025, 4:00 PM EDT
2.450
+0.020 (0.82%)
After-hours: Oct 3, 2025, 7:19 PM EDT

Inovio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
129661393891,0501,499
Upgrade
Market Cap Growth
-26.54%-52.55%-64.23%-62.93%-29.98%354.28%
Upgrade
Enterprise Value
92-621406881,237
Upgrade
Last Close Price
2.431.836.1218.7259.88106.20
Upgrade
PS Ratio
708.23303.38167.3337.93591.53202.30
Upgrade
PB Ratio
3.130.961.191.752.633.25
Upgrade
P/TBV Ratio
4.530.961.191.862.723.35
Upgrade
EV/Sales Ratio
505.91-1.8613.62387.68166.88
Upgrade
Debt / Equity Ratio
0.370.170.260.140.080.09
Upgrade
Asset Turnover
0.000.000.000.020.000.02
Upgrade
Quick Ratio
1.532.703.472.736.2310.33
Upgrade
Current Ratio
1.662.773.603.256.8211.30
Upgrade
Return on Equity (ROE)
-140.11%-115.42%-79.55%-89.97%-70.55%-71.79%
Upgrade
Return on Assets (ROA)
-59.30%-49.45%-30.50%-37.53%-36.35%-22.68%
Upgrade
Return on Capital (ROIC)
-80.46%-61.64%-39.41%-46.13%-40.36%-25.63%
Upgrade
Earnings Yield
-67.96%-162.35%-97.05%-71.89%-28.93%-11.10%
Upgrade
FCF Yield
-73.47%-158.28%-89.56%-55.80%-20.66%-11.97%
Upgrade
Buyback Yield / Dilution
-41.82%-22.49%-11.51%-14.27%-34.62%-57.14%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q